Physicians Realty Trust (NYSE:DOC) has received a Market Outperform recommendation from JMP Securities as reported by Fintel on May 26, 2023.
The average one-year price target for DOC is 16.38 with a high and low forecasted price target of $19.95 and $14.14, respectively. This indicates a potential upside of about 20.38% from the latest closing price of $13.61.
The projected annual revenue for the company is expected to increase by 3.09% to 546MM, with a projected annual non-GAAP EPS of 0.23. Physicians Realty Trust declared a regular quarterly dividend of $0.23 per share ($0.92 annualized) on March 17, 2023. Shareholders of record as of April 4, 2023, received the payment on April 18, 2023.
At the current share price of $13.61, the stock’s dividend yield is 6.76%. Looking back five years and taking a sample every week, the average dividend yield has been 5.38%, with a low of 4.45% and a high of 7.35%. The current dividend yield is 2.79 standard deviations above the historical average.
Physicians Realty Trust’s dividend payout ratio is 2.16, indicating that only a portion of the company’s income is paid out in dividends.
There are currently 744 funds or institutions reporting positions in Physicians Realty Trust, and the “put/call ratio” of DOC is 0.40, indicating a bullish outlook.
Physicians Realty Trust is a self-managed healthcare real estate company that invests in real estate leased to healthcare providers. They operate through an UPREIT structure and are the sole general partner of Physicians Realty L.P., which owns their properties.
Key filings for Physicians Realty Trust can be found on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
